These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31131897)

  • 1. Melatonin: A new inhibitor agent for cervical cancer treatment.
    Shafabakhsh R; Reiter RJ; Mirzaei H; Teymoordash SN; Asemi Z
    J Cell Physiol; 2019 Dec; 234(12):21670-21682. PubMed ID: 31131897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin in cancer management: progress and promise.
    Jung B; Ahmad N
    Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
    Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
    J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential therapeutic actions of melatonin in colorectal cancer.
    Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
    Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of melatonin in prevention and treatment of lung cancer.
    Ngai ZN; Chok KC; Ng KY; Koh RY; Chye SM
    Horm Mol Biol Clin Investig; 2022 Dec; 43(4):485-503. PubMed ID: 35728260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Biological Functions of Melatonin in Endometrial Cancer.
    Dana PM; Sadoughi F; Mobini M; Shafabakhsh R; Chaichian S; Moazzami B; Chamani M; Asemi Z
    Curr Drug Targets; 2020; 21(5):519-526. PubMed ID: 31560286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation.
    Pariente R; Pariente JA; Rodríguez AB; Espino J
    J Pineal Res; 2016 Jan; 60(1):55-64. PubMed ID: 26462739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin, experimental basis for a possible application in breast cancer prevention and treatment.
    Cos S; Sánchez-Barceló EJ
    Histol Histopathol; 2000 Apr; 15(2):637-47. PubMed ID: 10809385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential utility of melatonin in the treatment of childhood cancer.
    Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
    J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
    Samanta S
    Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin: A promising agent targeting leukemia.
    Shafabakhsh R; Mirzaei H; Asemi Z
    J Cell Biochem; 2020 Apr; 121(4):2730-2738. PubMed ID: 31713261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin as a potential inhibitor of colorectal cancer: Molecular mechanisms.
    Shafabakhsh R; Reiter RJ; Davoodabadi A; Asemi Z
    J Cell Biochem; 2019 Aug; 120(8):12216-12223. PubMed ID: 31087705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol and Cervical Cancer: A New Therapeutic Option.
    Shafabakhsh R; Reiter RJ; Aschner M; Mirzaei H; Asemi Z
    Mini Rev Med Chem; 2023; 23(2):159-169. PubMed ID: 35088669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin as a potential anticarcinogen for non-small-cell lung cancer.
    Ma Z; Yang Y; Fan C; Han J; Wang D; Di S; Hu W; Liu D; Li X; Reiter RJ; Yan X
    Oncotarget; 2016 Jul; 7(29):46768-46784. PubMed ID: 27102150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of melatonin in skin cancer treatment: A review of current biological evidence.
    Pourhanifeh MH; Mahdavinia M; Reiter RJ; Asemi Z
    J Cell Physiol; 2019 Aug; 234(8):12142-12148. PubMed ID: 30618091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
    Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
    Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and its ubiquitous anticancer effects.
    Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
    Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.